anonymous
Guest
anonymous
Guest
Carol orders the car whenever she feels like it and maybe she doesn't feel like it sometimes. That ding dong!
oh you will drive it, and like it!
We are told that the fleet vehicle are delayed bc of chip shortages. I wonder if they are delaying bc Amgen is anticipating a downsizing that will occur once the Horizon reps enter the fold. Think about the overlap.
Nothing describes Amgen's efficiency like passing along 2 year old Subaru Forester that has 40k miles and smells of Chipolte. Good news is that if you get this green friendly whip you might have a mixed cd that contains songs from Sarah McLachan, KD Lang, Broadway show tunes, Celine and Adele. That's a bonus!
They aren't laying off any sales from Horizon...they already operate thin. If anything we will add to them and then lay off in a few years. Same thing we are doing with Chemocentryx now.
There will be no layoffs on the Horizon side. Amgen added rare disease to their commercial portfolio that already includes immunology, oncology and general medicine. Rare disease requires specialized skills and experience.
You are foolish to think that there won't be any layoffs. You must be a Horizon employee that is drinking the Kool-Aid. Here is what will happen:
You will run independent for 6-12 months and slowly be integrated. The first round of layoffs will be your admin and support staff. They released the admin Chemocentryx team out on San Fran in the first 3-4 months. They will then go after your operational staff (marketing, access and trainers). Then they will integrate the team into Amgen's field where both Amgen legacy and your team will be thinned down.
Your statement, "Rare disease requires specialized skills and experience" is bs. I sold rare disease. You are still slinging Starbucks and feeding the office cows Olive Garden. Quit acting like your special. You are not.
If you have seen one rep, you have seen them allYou are 100% incorrect. You should mark this link down and revisit it in 2 years. Differences between Horizon and Amgen are far and wide. First we already run a very tight ship- we have roughly 60 people in a sales sleeve covering the whole country. In Neuro its more like 45. Tepezza does roughly 2 billion in sales from 60 reps. Krystexxa right around a billion with 140 (60 Rheum/60 Neph/20 Referral). Compare that to Enbrel and the revenue each rep brings in.
As far as rare disease and infusion products- if you think its the same then you are telling me you haven't sold anything rare without telling me that. RA isn't rare. You could say the AS indication was rare but that was just an extra indication that I'm sure you guys paid little attention too. Oncology isn't rare but its also a different breed- and those that say that is the same have also never really done it.
Amgen will be adding reps to Horizon to subtracting. Just having to spell this out to an Amgen drone is yet another instance of how reps at Horizon think bigger and more strategic. Continue to focus on your call metrics it’s obviously working for you. I'll continue to sell in the rare disease space and make just under 400k this year. Big difference between you and I just like a big difference between an Amgen rep and a Horizon rep.
You are 100% incorrect. You should mark this link down and revisit it in 2 years. Differences between Horizon and Amgen are far and wide. First we already run a very tight ship- we have roughly 60 people in a sales sleeve covering the whole country. In Neuro its more like 45. Tepezza does roughly 2 billion in sales from 60 reps. Krystexxa right around a billion with 140 (60 Rheum/60 Neph/20 Referral). Compare that to Enbrel and the revenue each rep brings in.
As far as rare disease and infusion products- if you think its the same then you are telling me you haven't sold anything rare without telling me that. RA isn't rare. You could say the AS indication was rare but that was just an extra indication that I'm sure you guys paid little attention too. Oncology isn't rare but its also a different breed- and those that say that is the same have also never really done it.
Amgen will be adding reps to Horizon to subtracting. Just having to spell this out to an Amgen drone is yet another instance of how reps at Horizon think bigger and more strategic. Continue to focus on your call metrics its obviously working for you. I'll continue to sell in the rare disease space and make just under 400k this year. Big difference between you and I just like a big difference between an Amgen rep and a Horizon rep.
You are 100% incorrect. You should mark this link down and revisit it in 2 years. Differences between Horizon and Amgen are far and wide. First we already run a very tight ship- we have roughly 60 people in a sales sleeve covering the whole country. In Neuro its more like 45. Tepezza does roughly 2 billion in sales from 60 reps. Krystexxa right around a billion with 140 (60 Rheum/60 Neph/20 Referral). Compare that to Enbrel and the revenue each rep brings in.
As far as rare disease and infusion products- if you think its the same then you are telling me you haven't sold anything rare without telling me that. RA isn't rare. You could say the AS indication was rare but that was just an extra indication that I'm sure you guys paid little attention too. Oncology isn't rare but its also a different breed- and those that say that is the same have also never really done it.
Amgen will be adding reps to Horizon to subtracting. Just having to spell this out to an Amgen drone is yet another instance of how reps at Horizon think bigger and more strategic. Continue to focus on your call metrics its obviously working for you. I'll continue to sell in the rare disease space and make just under 400k this year. Big difference between you and I just like a big difference between an Amgen rep and a Horizon rep.
You are 100% incorrect. You should mark this link down and revisit it in 2 years. Differences between Horizon and Amgen are far and wide. First we already run a very tight ship- we have roughly 60 people in a sales sleeve covering the whole country. In Neuro its more like 45. Tepezza does roughly 2 billion in sales from 60 reps. Krystexxa right around a billion with 140 (60 Rheum/60 Neph/20 Referral). Compare that to Enbrel and the revenue each rep brings in.
As far as rare disease and infusion products- if you think its the same then you are telling me you haven't sold anything rare without telling me that. RA isn't rare. You could say the AS indication was rare but that was just an extra indication that I'm sure you guys paid little attention too. Oncology isn't rare but its also a different breed- and those that say that is the same have also never really done it.
Amgen will be adding reps to Horizon to subtracting. Just having to spell this out to an Amgen drone is yet another instance of how reps at Horizon think bigger and more strategic. Continue to focus on your call metrics its obviously working for you. I'll continue to sell in the rare disease space and make just under 400k this year. Big difference between you and I just like a big difference between an Amgen rep and a Horizon rep.
and here we are with the same fucking business card...
You know the rare disease business unitSame company name on the business card...yes. But nothing else- culture, pay, metrics, RSU grants is the same.
You have a great understanding of rare disease. The rep’s skillsets, disease state knowledge, product marketing, unique MOA, route of administration, process to start therapy, HCP buy-in are all very specialized. Rare disease is completely different from selling an Enbrel injection or an Otezla pill. I’m looking for get into the rare disease side of the business.
You know the rare disease business unit
You are 100% incorrect. You should mark this link down and revisit it in 2 years. Differences between Horizon and Amgen are far and wide. First we already run a very tight ship- we have roughly 60 people in a sales sleeve covering the whole country. In Neuro its more like 45. Tepezza does roughly 2 billion in sales from 60 reps. Krystexxa right around a billion with 140 (60 Rheum/60 Neph/20 Referral). Compare that to Enbrel and the revenue each rep brings in.
As far as rare disease and infusion products- if you think its the same then you are telling me you haven't sold anything rare without telling me that. RA isn't rare. You could say the AS indication was rare but that was just an extra indication that I'm sure you guys paid little attention too. Oncology isn't rare but its also a different breed- and those that say that is the same have also never really done it.
Amgen will be adding reps to Horizon to subtracting. Just having to spell this out to an Amgen drone is yet another instance of how reps at Horizon think bigger and more strategic. Continue to focus on your call metrics its obviously working for you. I'll continue to sell in the rare disease space and make just under 400k this year. Big difference between you and I just like a big difference between an Amgen rep and a Horizon rep.
Give it a rest skippy. You are a drug rep. You had a nice run of thinking you were special. It’s over.
you deliver lunch like everyone else
you Set up speaker programs like everyone else
You fall back on medical for anything you aren’t allowed to discuss like everyone else
You rely on reimbursement and access folks when there is a hurdle like everyone else
your blathering about revenue generated only proves you had an overly priced drug for gout and dry eye. BFD.
if it makes you feel better, we can see if Amgen will put a little gold star on your business card.
What we talk about and how we talk at lunch differs from most reps. Especially ones that sell orals.
Speaker programs are done frequently and with strategic people attending- does anyone go to Enbrel talks?
Never have used Medical
Don't need reimbursement either- 90% of my offices don't use hub services because they don't need them.
Its quite different- you wouldn't know because your numbers are largely determined by formulary vs. actually selling.
Actually, I would know.
I have launched products in the rare disease and specialty space, designed access models and built HUB services.
I have also worked closely with both Horizon and Amgen.
The only difference is the paycheck despite what you tell yourself to feel superior.